← Back to Search

Dietary Supplement

Flax "milk" for Cardiotoxicity (CANFLAX Trial)

N/A
Waitlist Available
Led By Davinder S Jassal, MD
Research Sponsored by St. Boniface Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
i) ≥18 years old;
ii) women with newly diagnosed early stage breast cancer (Stage I-IIIA)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

CANFLAX Trial Summary

This trial is examining the use of flaxseed to prevent heart failure in women with breast cancer who are also receiving treatment with doxorubicin and trastuzumab.

CANFLAX Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

CANFLAX Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Left ventricular ejection fraction (LVEF) change

CANFLAX Trial Design

2Treatment groups
Experimental Treatment
Group I: Oat fibre "milk"Experimental Treatment1 Intervention
A total of 30 women will receive the oat fiber "milk" on a daily basis for a total of 4 months. The oat fibre "milk" will be composed of oat fibre, various gums for texture, vanilla flavoring, several minor ingredients, and water.
Group II: Flax "milk"Experimental Treatment1 Intervention
A total of 30 women will receive flax (FLX) "milk" on a daily basis for a total of 4 months. The FLX "milk" will be composed of BevPur (30 mesh FLX), various gums for texture, vanilla flavoring, several minor ingredients, and water. Each serving contains 15 grams of FLX and 3.75 grams of Omega-3.

Find a Location

Who is running the clinical trial?

St. Boniface HospitalLead Sponsor
51 Previous Clinical Trials
11,549 Total Patients Enrolled
2 Trials studying Cardiotoxicity
378 Patients Enrolled for Cardiotoxicity
Davinder S Jassal, MDPrincipal InvestigatorUniversity of Manitoba

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research endeavor currently enrolling participants?

"Affirmative, the information hosted on clinicaltrials.gov indicates that this medical trial is presently recruiting individuals to take part in it. It was initially posted on October 21st 2020 and recently updated on November 11th 2020. Sixty people must be enrolled across a single site for the study's completion."

Answered by AI

To what extent is the population of this experiment increasing?

"Affirmative. The information available on clinicaltrials.gov indicates that this medical experiment is actively seeking participants, having been posted on October 21st 2020 and last updated November 11th 2020. 60 patients must be recruited from a single site to complete the trial requirements."

Answered by AI
~14 spots leftby Mar 2025